Relationship between dose of antithyroid drugs and adverse events in pediatric patients with Graves’ disease

Graves’ disease (GD) accounts for a large proportion of pediatric hyperthyroidism, and the first-line treatment is antithyroid drug (ATD) therapy. Methimazole (MMI) is effective in most patients but is associated with significant adverse events (AEs). We reviewed the medical records of GD patients (...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Pediatr Endocrinol
Main Authors: Yasuda, Kie, Miyoshi, Yoko, Tachibana, Makiko, Namba, Noriyuki, Miki, Kazunori, Nakata, Yukiko, Takano, Toru, Ozono, Keiichi
Formato: Artigo
Idioma:Inglês
Publicado em: The Japanese Society for Pediatric Endocrinology 2017
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5295245/
https://ncbi.nlm.nih.gov/pubmed/28203042
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1297/cpe.26.1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados